Institution of an Italian Registry and Biobank for Biological Sample Collection
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 18, 2025
Trial Information
Current as of April 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a national registry and biobank for patients with lymphatic malformations (ML), which are rare conditions that can cause growths in the lymphatic system, often appearing at birth or early childhood. The purpose of the registry is to gather important information about these malformations, including how common they are and how they affect different patients. The biobank will collect biological samples from participants to support future research, helping scientists better understand ML and develop new treatments.
Anyone aged 0 to 100 who has been diagnosed with any type of lymphatic malformation can participate in this trial, provided they give their consent. Participants can expect to be part of a comprehensive study that looks at their medical history, treatment outcomes, and how ML impacts their lives. This research aims to improve care for patients with ML and to create better treatment guidelines, ensuring that families receive the best possible support and information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 0-100 years
- • 2. Signed informed consent.
- • 3. Individuals with any type of ML (isolated, syndromic, congenital or acquired, with or without molecular confirmation) identified by participating centers
- Exclusion Criteria:
- • Patients whose clinical picture is not compatible with points a) (b) and (c) of the inclusion criteria, as assessed by the Investigator.
Trial Officials
Chiara Leoni
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported